Skip to main content

Southwell David P

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Southwell David P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PTCT PTC Therapeutics, Inc.

Director4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 11, 2025 (view filing)Sep 92 daysSouthwell David PDirectorSSale−12.0K$58.34−$700.1K−41.6%16.9K after
Apr 19, 2023 (view filing)Apr 172 daysSouthwell David PDirectorSSale−11.4K$51.03−$583.2K−52.1%10.5K after2 lots10b5-1
Apr 4, 2023 (view filing)Mar 314 daysSouthwell David PDirectorSSale−2.57K$50.05−$128.7K−19.7%10.5K after10b5-1
Mar 29, 2023 (view filing)Mar 272 daysSouthwell David PDirectorSSale−10.0K$45.09−$450.9K−48.8%10.5K after3 lots10b5-1

RCKT Rocket Pharmaceuticals, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 16, 2024 (view filing)Apr 12-154 daysSouthwell David PDirectorSSale−80.0K$24.32−$1.95M−41.1%114.8K after3 lots

TCRX TScan Therapeutics, Inc.

Chief Executive Officer2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 20, 2022 (view filing)May 182 daysSouthwell David PChief Executive OfficerPPurchaseVoting Common Stock+25.0K$3.59+$89.8K+17.1%171.6K after2 lots
Sep 9, 2021 (view filing)Sep 81 daySouthwell David PChief Executive OfficerPPurchaseVoting Common Stock+11.0K$8.73+$96.0K+12.7%97.9K after